Associated Papers
MIG6 Mediates Adaptive and Acquired Resistance to ALK/ROS1 Fusion Kinase Inhibition through EGFR Bypass Signaling.
Chen N et al.
Molecular Cancer Therapeutics, 2024
37748191 (PubMed )
Supplement: mct-23-0218_supplementary_figures_s1-9_suppsf1-9.pdf
Select a paper to view details